Compare RDWR & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDWR | TNDM |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2000 | 2013 |
| Metric | RDWR | TNDM |
|---|---|---|
| Price | $29.99 | $15.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 24 |
| Target Price | ★ $30.50 | $28.55 |
| AVG Volume (30 Days) | 254.7K | ★ 2.0M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $10.09 | $5.69 |
| Revenue Next Year | $7.92 | $12.35 |
| P/E Ratio | $59.76 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $21.68 | $12.26 |
| 52 Week High | $32.79 | $29.65 |
| Indicator | RDWR | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 36.37 |
| Support Level | $26.61 | $14.54 |
| Resistance Level | $32.14 | $16.50 |
| Average True Range (ATR) | 1.13 | 0.99 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 46.56 | 30.78 |
Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.